ARTICLE |
ivi
njak, PhDa
a Department of Pediatrics, Hannover Medical School, Hannover, Germany
b Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas
Schimke-immuno-osseous dysplasia is a rare autosomal-recessive multisystem disorder with the main clinical features of disproportionate growth deficiency, defective cellular immunity, and progressive renal disease. It is caused by mutations of SMARCAL1, a gene encoding a putative chromatin remodeling protein of unknown function. Because a detailed description of the clinical features is an essential first step in elucidating the function of SMARCAL1, we present the first detailed anthropometric data for Schimke-immuno-osseous dysplasia patients. By comprehensive anthropometric examination (28 parameters) of 8 patients (3 females) with the typical findings of Schimke-immuno-osseous dysplasia (mean age: 14.8 years; range: 4.930.5 years) and 304 patients (117 females) with congenital and hereditary chronic kidney disease (mean age: 10.7 ± 4.8 years; range: 321.8 years), we show that Schimke-immuno-osseous dysplasia patients differ significantly from those with other forms of chronic kidney disease. z scores were calculated with reference limits derived from 5155 healthy children (2591 females) aged 3 to 18 years. The key finding was that, in the latter group, median leg length was significantly more reduced than sitting height, whereas in Schimke-immuno-osseous dysplasia patients, the reduction of sitting height was significantly more pronounced than for leg length. Therefore, the ratio of sitting height/leg length might be a simple tool for the clinician to distinguish Schimke-immuno-osseous dysplasia from other chronic kidney disease patients. Schimke-immuno-osseous dysplasia is very likely if this ratio is <0.83. However, other forms of chronic kidney disease have to be discussed in case of a ratio >1.01.
Key Words: anthropometry Schimke-immuno-osseous dysplasia chronic renal failure chronic kidney disease
Abbreviations: SIODSchimke-immuno-osseous dysplasia CKDchronic kidney disease SDSstandard deviation score
This article has been cited by other articles:
![]() |
T. Lucke, N. Kanzelmeyer, K. Chobanyan, D. Tsikas, D. Franke, M. J. Kemper, J. H.H. Ehrich, and A. M. Das Elevated asymmetric dimethylarginine (ADMA) and inverse correlation between circulating ADMA and glomerular filtration rate in children with sporadic focal segmental glomerulosclerosis (FSGS) Nephrol. Dial. Transplant., February 1, 2008; 23(2): 734 - 740. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Marietta Clewing, B. C Antalfy, T. Lucke, B. Najafian, K. M Marwedel, A. Hori, R. M Powel, A F Safo Do, L. Najera, K. SantaCruz, et al. Schimke immuno-osseous dysplasia: a clinicopathological correlation J. Med. Genet., February 1, 2007; 44(2): 122 - 130. [Abstract] [Full Text] [PDF] |
||||